Clover Biopharmaceuticals Selects GE Healthcare's FlexFactory for New Facility

GE Healthcare said today that its FlexFactory™ single-use biomanufacturing platform has been selected by Clover Biopharmaceuticals, a Chinese developer of biologics, for its new facility located in Changxing, Zhejiang.The new facility will primarily produce biological fusion protein products, including innovative drugs and biosimilars. The facility includes two 2000-liter bioreactors from GE, and will be operational in the latter half of 2018, Clover and GE Healthcare said.SCB-808, a prefi